Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Froelich

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Immunopharmacology and Immunotoxicology|January 21, 2010
Lentiviral vectors for immune cells targetingSteven Froelich, April Tai, Pin Wang
Biotechnology and Bioengineering|May 20, 2009
Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic moleculeSteven Froelich, Leslie Ziegler, Katie Stroup, et al.
Journal of Biological Engineering|February 1, 2011
Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cellsApril Tai, Steven Froelich, Kye-Il Joo, et al.
Plos One|July 9, 2011
Virus-receptor mediated transduction of dendritic cells by lentiviruses enveloped with glycoproteins derived from Semliki Forest virusSteven Froelich, April Tai, Katie Kennedy, et al.
Human Gene Therapy|April 2, 2011
Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cellsSteven Froelich, April Tai, Katie Kennedy, et al.
American Journal of Human Genetics|January 9, 2026
Functional analysis of NPR2 variants supports the therapeutic rationale for CNP in short statureRaehoon Jeong, Sergio Covarrubias, Devanshi Shanghavi, et al.
Genome Biology|July 21, 2023
Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrixMarena Trinidad, Xinying Hong, Steven Froelich, et al.
Nucleic Acid Therapeutics|February 7, 2025
Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular DystrophyTodd Oppeneer, Yulan Qi, Joshua Henshaw, et al.
Nature Communications|April 14, 2021
Identifying therapeutic drug targets using bidirectional effect genesKarol Estrada, Steven Froelich, Arthur Wuster, et al.
American Journal of Human Genetics|May 23, 2024
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variantsDina Buitrago Silva, Marena Trinidad, Alicia Ljungdahl, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Immunopharmacology and Immunotoxicology|January 21, 2010
Lentiviral vectors for immune cells targetingSteven Froelich, April Tai, Pin Wang
Biotechnology and Bioengineering|May 20, 2009
Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic moleculeSteven Froelich, Leslie Ziegler, Katie Stroup, et al.
Journal of Biological Engineering|February 1, 2011
Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cellsApril Tai, Steven Froelich, Kye-Il Joo, et al.
Plos One|July 9, 2011
Virus-receptor mediated transduction of dendritic cells by lentiviruses enveloped with glycoproteins derived from Semliki Forest virusSteven Froelich, April Tai, Katie Kennedy, et al.
Human Gene Therapy|April 2, 2011
Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cellsSteven Froelich, April Tai, Katie Kennedy, et al.
American Journal of Human Genetics|January 9, 2026
Functional analysis of NPR2 variants supports the therapeutic rationale for CNP in short statureRaehoon Jeong, Sergio Covarrubias, Devanshi Shanghavi, et al.
Genome Biology|July 21, 2023
Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrixMarena Trinidad, Xinying Hong, Steven Froelich, et al.
Nucleic Acid Therapeutics|February 7, 2025
Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular DystrophyTodd Oppeneer, Yulan Qi, Joshua Henshaw, et al.
Nature Communications|April 14, 2021
Identifying therapeutic drug targets using bidirectional effect genesKarol Estrada, Steven Froelich, Arthur Wuster, et al.
American Journal of Human Genetics|May 23, 2024
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variantsDina Buitrago Silva, Marena Trinidad, Alicia Ljungdahl, et al.
Pageof 2